Yadkin Valley Financial Corp., a holding company for Yadkin Valley Bank and Trust Company that offers consumer and commercial banking services in northwestern North Carolina, officially announced the closing of a $6.4 million capital raise. “We are greatly encouraged by … Continue reading →

Bacterin International Holdings Inc. is the developer of revolutionary bone graft material and antimicrobial coatings for a number of medical applications. The company’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and … Continue reading →

NovaBay Pharmaceuticals Inc., a clinical-stage biotech company developing compounds to fight bacteria, fungi and viruses, presented a poster at the 2011 Conference of the Association for Research in Vision and Ophthalmology (ARVO) held this week in Fort Lauderdale, Fla. The … Continue reading →

PhotoMedex, Inc., an industry leader of clinical skincare and laser products, introduced their innovative DNA Damage Control product. This product is much different than typical treatments and sunscreens in that it uses DNA to repair damaged skin. This product is … Continue reading →

Solta Medical reported today reception of FDA 501k clearance for the Company’s Clear + Brilliant treatment, which had previously received CE mark and is based on SLTM’s fractional laser technology. The Clear + Brilliant treatment will be officially launched at … Continue reading →

Cytori Therapeutics, Inc., a developer, manufacturer, and retailer of medical technologies to allow practice of regenerative medicine, has announced the appointment of Clyde W. Shores as the new Executive Vice President of Marketing and Sales. Clyde W. Shores will be … Continue reading →

Solta Medical reported today reception of FDA 501k clearance for the Company’s Clear + Brilliant treatment, which had previously received CE mark and is based on SLTM’s fractional laser technology. The Clear + Brilliant treatment will be officially launched at … Continue reading →

Located in China, SinoTech has rapidly evolved as a provider of enhanced oil recovery (“EOR”) services. Today, the company announced an updated financial outlook for fiscal year 2011. SinoTech also told investors that it will release its unaudited financial results … Continue reading →

DUSA Pharmaceuticals Inc., a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, reported a 27 percent increase in first-quarter revenues. “We are off to a great start … Continue reading →

Zynex Inc., a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, yesterday posted a 36% increase in first quarter 2011 earnings. Net revenue of $6.63 million is an increase of 36 percent compared … Continue reading →